peanut allergy
FDA approves first treatment for peanut allergy
February 3, 2020Sales and Marketing FDA, FDA Peanuts, peanut, peanut allergy, peanut medicine
The FDA has approved its first treatment for peanut allergy in patients between ages four and 17. The drug is …
Aimmune’s peanut allergy therapy recommended for approval by FDA committee
September 16, 2019Sales and Marketing Aimmune, FDA, peanut allergy, pharma
The FDA’s Allergenic Products Advisory Committee (APAC) has recommended the use of Aimmune Therapeutics’ AR101, also known by its proposed …
Aimmune’s peanut allergy candidate hits main endpoint at Phase 3
February 21, 2018Research and Development Aimmune, peanut, peanut allergy, pharma
US biopharmaceutical firm Aimmune has revealed that its peanut allergy candidate AR101 hit its primary endpoint in the largest trial …
Latest content
Pharma sees climate disruption as growing supply-chain risk
September 11, 2026
Manchester NHS-MHRA partnership to test new technologies in real-world care
September 10, 2026
